Profile
MTNB NVO VRTX REGN SGEN ALNY
Company Name Matinas BioPharma Holdings, Inc. Novo Nordisk A/S Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Seagen Inc. Alnylam Pharmaceuticals, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $15.90M $530.78B $125.13B $109.96B $43.15B $36.37B
Employees 0.03K 69.26K 5.40K 13.93K 3.26K 2.10K
CEO Mr. Jerome D. Jabbour J.D. Mr. Lars Fruergaard Jorgensen Dr. Reshma Kewalramani FASN, M.D. Dr. Leonard S. Schleifer M.D., Ph.D. Mr. David R. Epstein B.Sc., M.B.A. Dr. Yvonne L. Greenstreet M.B.A., MBChB
Ratings
MTNB NVO VRTX REGN SGEN ALNY
Quant Rating Score 1 3 2 4 3 2
Quant Rating Strong Sell Neutral Sell Buy Neutral Sell
Trading
MTNB NVO VRTX REGN SGEN ALNY
Last Close $3.17 $119.78 $484.82 $1014.25 $228.74 $283.32
High 52 $4 $146.91 $505.78 $1201.76 $228.9 $287.01
Low 52 $0.09 $93.5 $343 $775.18 $211.85 $143.31
Price vs. 52 Week High -20.75 % -18.47 % -4.14 % -15.6 % -0.07 % -1.29 %
Price vs. 52 Week Low 3422.22 % 28.11 % 41.35 % 30.84 % 7.97 % 97.7 %
Total Return
MTNB NVO VRTX REGN SGEN ALNY
1 Month Return -17.45 % -12.57 % -0.11 % -12.06 % 0 % 6.8 %
3 Month Return 1636.04 % -15.28 % -1.23 % -6.27 % 0 % 10.59 %
6 Month Return 1465.43 % -3.33 % 22.01 % 12.88 % 0 % 91.82 %
9 Month Return 1296.48 % 11.78 % 11.86 % 8.69 % 0 % 46.5 %
YTD Return 1366.23 % 15.79 % 19.15 % 15.48 % 0 % 48.02 %
1 Year Return 1400.95 % 17.27 % 30.68 % 20.8 % 6.87 % 68.52 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
MTNB NVO VRTX REGN SGEN ALNY
Dividend Yield Percentage (TTM) - 1.2 % - - - -
Dividend Paid and Capex Coverage Ration (TTM) -1117.06 % 1.26 % -1.96 % 4.72 % -3.35 % 6.97 %
Dividend Per Share (TTM) - 0.21 % - - - -
Payout Ratio (TTM) - 46.71 % - - - -
Growth
MTNB NVO VRTX REGN SGEN ALNY
Asset Growth 46.32 % 30.35 % 25.23 % 13.23 % -1.21 % 7.99 %
Gross Profit Growth 101.15 % 32.32 % 9.25 % 6.49 % 22.93 % 74.75 %
Revenue Growth -65.62 % 31.26 % 10.17 % 7.76 % 24.65 % 76.23 %
Revenue 3 Year 527.31 % 90.51 % 59.87 % 55.67 % 91.84 % 241.5 %
Revenue 5 Year 313.27 % 124.2 % 218.58 % 110.3 % 215.48 % 1865.57 %
Revenue 10 Year - 66.11 % 608.27 % 549.62 % 494.04 % 1810.11 %
EBIT Growth 3.35 % 37.11 % -12.94 % -14.6 % 10.13 % 64.06 %
Net Income Growth -76.27 % 50.71 % 8.96 % -8.87 % 9.51 % 61.08 %
Net Income 3 Yeari Growth Per Share -0.93 % 106.79 % 34.59 % 13.48 % -764.83 % 52.78 %
Net Income 5 Yeari Growth Per Share 26.44 % 133.86 % 70.33 % 74.02 % -276.93 % 53.44 %
Net Income 10 Yeari Growth Per Share 9 % 98.61 % 809.6 % 871.12 % -624.16 % -143.14 %
Operating Income Growth 3.35 % 37.11 % -12.94 % -14.6 % 10.13 % 64.06 %
Operating Cash Flow Growth (CFG) 20.24 % 38.06 % -14.35 % -8.39 % 9.07 % 119.24 %
Operating 3 Year CFG 20.28 % 118.29 % 9.63 % 76.95 % -148.34 % 115.59 %
Operating 5 Year CFG 33.16 % 163.51 % 174.78 % 125.17 % -195.86 % 114.91 %
Operating 10 Year CFG 24.69 % 150.92 % 6084.35 % 713.56 % -2622.09 % 174.76 %
EPS Growth -83.33 % 52.28 % 8.33 % -8.54 % 10.81 % 62.15 %
EPS Diluted Growth -83.33 % 52.37 % 8.35 % -9.03 % 10.81 % 62.15 %
Book Value Per Share -47.58 % 29 % 25.58 % 15.03 % -9.83 % -35.86 %
Share Holder 3 Year Equity Growth Per Share -72.63 % 75.22 % 104.06 % 137.56 % 33.92 % -119.99 %
Share Holder 5 Year Equity Growth Per Share -46.16 % 121.9 % 291.14 % 219.1 % 220.81 % -113.65 %
Share Holder 10 Year Equity Growth Per Share -72.94 % 49.62 % 1030.79 % 1286.9 % 691.19 % -140.22 %
Dividend Per Share Growth - 26.89 % - - - -
Dividend 3 Year Growth Per Share -100 % 64.4 % - - - -
Dividend 5 Year Growth Per Share -100 % 80.03 % - - - -
Dividend 10 Year Growth Per Share - 95.44 % - - - -
Debt Growth -13.77 % 4.74 % 44.1 % 0.06 % -23.28 % 103.19 %
Free Cash Flow Growth 22.71 % 9.17 % -16.47 % -17.11 % 3.67 % 106.84 %
Updated On 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2022 31 Dec 2023
Profitability
MTNB NVO VRTX REGN SGEN ALNY
Gross Profit Margin TTM 187.5 % 84.53 % 86.43 % 86.08 % 75.4 % 87 %
Return on Assets TTM -94.04 % 24.34 % -2.43 % 11.98 % -20.64 % -1.82 %
Return on Equity TTM -120.5 % 87.5 % -2.91 % 16.3 % -28.06 % 47.92 %
Return on Capital Employed TTM -108.14 % 61.51 % -2.36 % 12.08 % -29.5 % 3.47 %
Net Income Per EBT TTM 100 % 79.6 % -228.18 % 94.21 % 101.53 % 118.22 %
EBT Per Ebit TTM 96.42 % 101.17 % -54.74 % 116.55 % 93.47 % -60.11 %
EBIT Per Revenue TTM 2168.07 % 43.26 % -3.8 % 29.18 % -34.37 % 4.38 %
Cash Flow To Debt Ratio TTM -551.47 % 202.13 % -101.14 % 205.21 % -475.96 % 15.08 %
Receivables Turnover TTM - 3.88 6.23 2.36 3.64 7.58
Payables Turnover TTM 4.03 1.34 4.27 3.34 2.52 4.12
Inventory Turnover TTM - 1.1 1.53 0.65 1.07 3.63
Fixed Asset Turnover TTM -24.21 % 234.59 % 583 % 313.27 % 471.71 % 327.68 %
Asset Turnover TTM -4.5 % 69.85 % 51.28 % 37.38 % 63.3 % 58.47 %
Operating Cash Flow Per Share TTM -0.07 25.87 -3.66 37.65 -2.87 2.94
Free Cash Flow Per Share TTM -0.07 14.81 -5.52 29.68 -3.73 2.52
Cash Per Share TTM 5.76 % 1405.52 % 2245.45 % 9080.94 % 657.5 % 2071.01 %
Operating Cash Flow Sales Ratio TTM 1630.75 % 44.7 % -9.14 % 30.18 % -23.48 % 15.88 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.09 % 57.25 % 151.04 % 78.82 % 129.82 % 85.66 %
Cash Flow Coverage Ratios TTM -551.47 % 202.13 % -101.14 % 205.21 % -475.96 % 15.08 %
Price To Free Cash Flows Ratio TTM -0.89 54.96 -87.76 34.27 -61.54 114.07
Price To Operating Cash Flows Ratio TTM -44.23 31.65 -132.56 26.94 -79.67 96.45
Price Cash Flow Ratio TTM -44.23 31.65 -132.56 26.94 -79.67 96.45
Income Statement (TTM)
MTNB NVO VRTX REGN SGEN ALNY
Revenue $0B $232.26B $9.84B $13.12B $1.96B $1.83B
Gross Profit $0B $196.5B $8.58B $11.3B $1.55B $1.52B
Gross Profit Ratio 14.14% 84.6% 87.17% 86.16% 79.1% 83.02%
EBITDA $-0.02B $112.94B $3.93B $5.13B $-0.62B $-0.23B
Net Income $-0.02B $83.68B $3.62B $3.95B $-0.61B $-0.44B
EPS Diluted -0.11 18.62 13.89 34.77 -3.3 -3.52
Balance Sheet (MRQ)
MTNB NVO VRTX REGN SGEN ALNY
Long Term Debt $0B $20.53B $0.72B $2.7B $0.04B $2.34B
Total Liabilities $0.05B $207.93B $5.15B $7.11B $0.87B $4.05B
Total Equity $0.02B $106.56B $17.58B $25.97B $2.8B $-0.22B
Total Investments $0.01B $17.5B $3.45B $13.51B $1.42B $1.68B
Total Debt $0B $27.01B $0.81B $2.7B $0.04B $2.68B
Total Assets $0.07B $314.49B $22.73B $33.08B $3.67B $3.83B
Cash Flow Statement (TTM)
MTNB NVO VRTX REGN SGEN ALNY
Net Income $-0.02B $83.68B $3.62B $3.95B $-0.61B $-0.44B
Inventory $0B $-7.42B $-0.32B $-0.27B $-0.23B $0.02B
Dividends Paid $0B $-31.77B $0B $0B $0B $0B
Operating Cash Flow $-0.02B $108.91B $3.54B $4.59B $-0.45B $0.1B
Capital Expenditure $-0B $-38.9B $-0.26B $-0.93B $-0.08B $-0.06B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.13
ABCL AbCellera Biologics Inc. 2.56
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 6.54
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 2.33
ABSI Absci Corporation 3.98
ABUS Arbutus Biopharma Corporation 4.11
ABVC ABVC BioPharma, Inc. 0.5871
ABVX Abivax SA American Depositary Shares 9.48
ACAD ACADIA Pharmaceuticals Inc. 14.91
ACER Acer Therapeutics Inc. 0.9
ACET Adicet Bio, Inc. 1.4
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 0.985
ACHV Achieve Life Sciences, Inc. 5.005
ACIU AC Immune SA 3.2
ACLX Arcellx, Inc. 89.91
ACRV Acrivon Therapeutics, Inc. Common Stock 7.6
ACST Acasti Pharma Inc. 3.39
ETFs With Exposure to MTNB
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0 286.36
IBB iShares Biotechnology ETF 0.01 145.82
ITOT iShares Core S&P Total U.S. Stock Market ETF 0 127.088
VXF Vanguard Extended Market Index Fund 0 185.49
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0 99.26
VITPX Vanguard Institutional Total Stock Market Index Fund Institutional Plus Shares 0 99.23
VBAIX Vanguard Balanced Index Fund Institutional Shares 0 49.98
VBIAX Vanguard Balanced Index Fund Admiral Shares 0 49.97
VBINX Vanguard Balanced Index Fund Investor Shares 0 49.97
VTSAX Vanguard Total Stock Market Index Fund 0 139.37
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 140.74
VITSX Vanguard Total Stock Market Index Fund 0 139.39
SWTSX Schwab Total Stock Market Index Fd Select Shs a Series of Schwab Capit 0.000141332 98.72
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 140.75
JKK iShares Morningstar Small-Cap Growth ETF 0.01 307.42
JKJ iShares Morningstar Small-Cap ETF 0.01 231.193
VEMPX Vanguard Extended Market Index InstlPlus 0 347.32
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 261.47
Unlock